Should Pharma Regain MES Leadership or Become the New IX Leaders?
Principal Analyst, Andrew Hughes, discusses the choice pharma companies need to make: regain their leadership in MES or become the new leaders in IX
Principal Analyst, Andrew Hughes, discusses the choice pharma companies need to make: regain their leadership in MES or become the new leaders in IX
Do lighthouse plants drive Industrial Transformation? LNS Research's Matthew Littlefield examines their implementation and how to better improve IX...
Find the answers with Principal Analyst Tom Comstock as he discusses three of the most commonly asked questions surrounding Digital Twin use cases.
Learn the facts on Reliance NXG in Principal Analyst Tom Comstock's review of ETQ's newest quality management software.
The LNS Research Solution Selection Matrix and Vendor Compendium evaluate vendors within the IX Platform ecosystem to create a shortlist of...
LNS Research Analyst Joe Perino discusses trends in Operational Excellence that affect EHS, the Connected Frontline Workforce, Quality, APM, and...
LNS Research Analyst Joe Perino examines the state of cybersecurity offerings and the importance of cybersecurity as a key element to risk management.
LNS Research Analyst Joe Perino looks at AVEVA's completed acquisition of OSIsoft and examines four issues with the integration, including the PI...
Research Analyst Pete Bussey re-assesses and refines LNS Research's definition of the connected worker space and the vendor landscape for industrial...
LNS Research Principal Analyst Andrew Hughes revisits 7 Lives of MOM and examines MES as a strategy to jumpstart Industrial Transformation.